US regulatory status: approved.
biotech · Plaque Psoriasis · Rheumatoid Arthritis · CANF
Can Fite Biopharma
Can-Fite BioPharma
Can Fite Biopharma drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
10 Bareket Street, פ"ת, IL, RAMAT GAN, L3, USA HQ
9 Employees
Public company Type
CANF · NYSE Ticker
Company details
- Status
- Public
- HQ
- 10 Bareket Street, פ"ת, IL, RAMAT GAN, L3, USA
- Employees
- 9
- Programs
- 20
- Drugs
- 4
- Patents
- 23
Can Fite Biopharma pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Can Fite Biopharma drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
covid-19 vaccine (inactivated, adjuvanted, adsorbed)
Antiinfectives for systemic use (J07)Antiinfectives for systemic use (J07) compound in Can Fite Biopharma's portfolio. Mechanism: Biological vaccine - induces immune response.
- Mechanism
- Biological vaccine - induces immune response
-
Development asset linked to Can Fite Biopharma in public FDA and regional records.
-
Development asset linked to Can Fite Biopharma in public FDA and regional records.